NANOBIOTIX NBTX
SPONSORED ADS · ADR · CUSIP 63009J107
- SectorHealth care
- IndustryPharmaceutical Preparations
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $5.11.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 6 |
| Q4 2022 | 6 |
| Q1 2023 | 5 |
| Q2 2023 | 6 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 1 | 0 |
| Q1 2023 | 0 | 2 |
| Q2 2023 | 2 | 0 |
Biggest buyers
| UBS Group AG | Added | +1.0k |
| JPMORGAN CHASE & CO | New | +2 |
Biggest sellers
| None |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Invus Global Management, LLC 13G · passive investor +0.5 pts · filed 2026-08-13 | 9.4% |
| Qatar Investment Authority 13G · passive investor filed 2026-07-29 | 7.0% |
Insider purchases and sales in Q2 2023
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2023.
Holders, Q2 2023
| Manager | Shares | Change |
|---|---|---|
| BAILLIE GIFFORD & CO 0.01% of their portfolio | 1.4m $7.3m | Unchanged |
| PERCEPTIVE ADVISORS LLC 0.16% of their portfolio | 1.1m $5.4m | Unchanged |
| Artal Group S.A. 0.16% of their portfolio | 1.0m $5.1m | Unchanged |
| UBS Group AG 0.00% of their portfolio | 4.0k $20.3k | Added +1.0k |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 2 $10 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |